您已经顶过了!
前列腺癌的疾病特点因人而异,诊断和治疗手段丰富多样,治疗效果也各不相同。
面对复杂的疾病特征,追求最优的诊治效果是泌尿外科医生的终极目标。
在这里整理自己发表的前列腺癌手术视频和论文,供病友参考,一起更好的了解和诊治前列腺癌。
手术视频(收录于泌尿手术视频网站,浏览超过6000次):
1. 朱耀教授:腹腔镜根治性前列腺切除术
RH阴性熊猫血患者的腹腔镜前列腺癌根治手术,视频网址:http://www.allmedv.com/make/tucao/2948.html
2. 朱耀教授:腔镜下精细保留性神经和功能尿道
年轻前列腺癌患者保留性功能和排尿功能的腹腔镜前列腺癌根治手术,视频网址:http://www.allmedv.com/make/tucao/3048.html
国外论文(共18篇,收录于欧美权威杂志):
第一部分,前列腺癌早期诊断:
[1] Zhu Y, Han CT, Zhang GM, et al. Effect of Body mass index on the performance characteristics of PSA-related markers to detect prostate cancer. Sci Rep. 2016 Jan 12;6:19034.
[2] Zhu Y, Han CT, Zhang GM, et al. Development and external validation of a prostate health index-based nomogram for predicting prostate cancer. Sci Rep. 2015 Oct 16;5:15341.
[3] Zhang GM, Zhu Y, Chen HT, et al Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China. Medicine (Baltimore). 2015 Oct;94(42):e1603.
[4] Zhang G, Zhu Y, Liu F, et al. Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men. Onco Targets Ther. 2015 Dec 22;9:61-6.
[5] Gu C, Li Q, Zhu Y, et al. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence. Prostate Cancer Prostatic Dis. 2015 Dec;18(4):310-6.
[6] Zhu Y, Han CT, Chen HT, et al Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort. Oncotarget. 2015 Sep 8;6(26):22978-84.
[7] Zhang GM, Zhu Y, Dong DH, et al. The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy. Asian J Androl. 2015 Sep-Oct;17(5):839-44.
[8] Li Q, Gu C, Zhu Y, et al. Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population. Mol Carcinog. 2015 Aug;54(8):632-41.
[9] Gu CY, Li QX, Zhu Y, et al. Genetic variations of the ADIPOQgene and risk of prostate cancer in Chinese Han men. Asian J Androl. 2014 Nov-Dec;16(6):878-83.
[10] Li Q, Gu C, Zhu Y, et al. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population. PLoS One. 2013 Aug 5;8(8):e71968.
[11] Zhu Y, Wang JY, Shen YJ, et al. External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort. Asian J Androl. 2012 Sep;14(5):738-44.
第二部分,高危前列腺癌手术治疗:
[1] Gu C, Qu Y, Zhang G, Sun L, Zhu Y, Ye D. A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer. Oncotarget. 2015 Oct 13;6(31):32205-11.
[2] Zhang GM, Zhu Y, Ma XC, et al. Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy. Medicine (Baltimore). 2015 Oct;94(41):e1473.
[3] Zhu Y, Wang HK, Qu YY, et al. Prostate cancer in East Asia: evolving trend over the last decade. Asian J Androl. 2015 Jan-Feb;17(1):48-57.
[4] Zhu Y, Yang XQ, Han CT, et al. Pathological features of localized prostate cancer in China: a contemporary analysis of radical prostatectomy specimens. PLoS One. 2015 Mar 23;10(3):e0121076.
[5] Zhu Y, Ye DW. Prostate cancer: alkaline phosphatase velocity in nonmetastatic CRPC. Nat Rev Urol. 2014 Dec;11(12):666-7.
[6] Wang JY, Zhu Y, Wang CF, Zhang SL, Dai B, Ye DW. A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients. Chin J Cancer. 2014 May;33(5):241-8.
第三部分,晚期前列腺癌治疗方案:
[1] Bian XJ, Zhu Y, Shen YJ, et al. The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancer. Asian J Androl. 2013 Sep;15(5):679-84.
国内论文(共13篇,发表于国内核心期刊):
第一部分,国内前列腺癌整体情况:
[1]叶定伟, 朱耀. 中国前列腺癌的流行病学概述和启示[J]. 中华外科杂志, 2015, 53(4).
[2]叶定伟, 朱耀. 西式生活助长前列腺癌[J]. 大众医学, 2006(3):19-19.
第二部分,前列腺癌规范治疗选择:
[1]顾成元, 朱耀. 主动监测在局限性低危前列腺癌中的应用[J]. 现代泌尿外科杂志, 2014(6):415-418.
[2]叶定伟, 顾成元, 朱耀. NCCN前列腺癌临床实践指南亚洲共识(V2.2013版)要点解读与分析[J]. 中华外科杂志, 2015, 53(1).
[3]周家权, 朱耀, 姚旭东,等. 初诊前列腺癌患者骨转移预测模型的建立及验证[J]. 中华外科杂志, 2012, 50(11).
[4]周家权, 朱耀, 姚旭东,等. 初诊前列腺癌骨扫描的必要性分析[J]. 中华医学杂志, 2013, 93(4).
[5]朱耀, 叶定伟. 局部高危前列腺癌的新辅助化疗[J]. 中华泌尿外科杂志, 2006, 27(9):641-643.
[6]叶定伟, 朱耀. 前列腺癌内分泌治疗的几个热点问题[J]. 临床外科杂志, 2006, 14(2):86-87.
第三部分,高难度前列腺癌根治手术:
[1]朱耀, 韩成涛, 杨晓群,等. 腹腔镜和开放前列腺癌根治术后配对比较切缘阳性情况[J]. 现代泌尿外科杂志, 2015(4):234-236.
[2]万方宁, 朱耀, 周家权,等. 高龄患者前列腺癌根治术的围手术期并发症分析[J]. 中华外科杂志, 2012, 50(11).
[3]万方宁, 周家权, 朱耀,等. 预测前列腺癌根治术后并发症风险列线图的建立[J]. 中华泌尿外科杂志, 2012, 33(7).
第四部分,前列腺癌科学研究:
[1]吴俊龙, 朱耀, 叶定伟. 睾酮与前列腺癌关系研究进展[J]. 现代泌尿外科杂志, 2015, 20(10):751-754.
[2]顾成元, 李巧新, 朱耀,等. 脂联素基因多态性与前列腺癌发病风险的相关性研究[J]. 中华泌尿外科杂志, 2014, 35(5).
提示x
您已经顶过了!
版权所有:杭州微医健康科技有限公司 浙B2-20200356 浙卫(03)网审[2014]015号 (浙)-经营性-2014-0022